Latest News

Experts Expect New Human Cases of Avian Flu


 

Antiviral Drugs

There are four FDA-approved antivirals for influenza: Oseltamivir phosphate (available as a generic drug or by the trade name Tamiflu), zanamivir (Relenza), peramivir (Rapivab) , and baloxavir (Xofluza).

For people with suspected or confirmed avian influenza, treatment is recommended as soon as possible.

There are no clinical trials measuring the outcome of antivirals in people infected with avian influenza. However, data from animal models and human observational studies suggest a benefit.

“We can’t afford to wait this summer,” Dr. Krammer said. “We have an opportunity right now to stop this in cows before we risk infecting more people. I hope we do.”

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

More Evidence Suggests That ‘Long Flu’ Is a Thing
MDedge Infectious Disease
Do Kids With an October Birthday Have Protection From Flu?
MDedge Infectious Disease
Midwife’s Fake Vaccinations Deserve Harsh Punishment: Ethicist
MDedge Infectious Disease
Flu Vaccines to Change After COVID Kills Off One Strain of Virus
MDedge Infectious Disease
Systematic Viral Testing in Emergency Departments Has Limited Benefit for General Population
MDedge Infectious Disease
COVID Levels Decline, but Other Viruses Remain High
MDedge Infectious Disease
Severe Flu Confers Higher Risk for Neurologic Disorders Versus COVID
MDedge Infectious Disease
Digital Nudges Found to Be Duds in Flu Vax Trial
MDedge Infectious Disease
European Scientists Assess Avian Flu Pandemic Risk
MDedge Infectious Disease
Avian Flu Threat Still Low and Vaccine Measures Are Ready
MDedge Infectious Disease